Cargando…
N2 modified cap analogues as translation inhibitors and substrates for preparation of therapeutic mRNA
In recent years many scientists have begun to focus on the mRNA molecule’s emeregence as a new type of drug. Its fast-moving and successful career as a vaccine technology cannot be underestimated. mRNA provides new opportunities and allows for the rapid preparation of effective drugs at low cost. Th...
Autores principales: | Kurpiejewski, Karol, Jankowska-Anyszka, Marzena, Grzela, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618310/ https://www.ncbi.nlm.nih.gov/pubmed/37656232 http://dx.doi.org/10.1007/s00249-023-01676-7 |
Ejemplares similares
-
N2 modified dinucleotide cap analogs as a potent tool for mRNA engineering
por: Grzela, Renata, et al.
Publicado: (2023) -
Triazole-containing monophosphate mRNA cap analogs as effective translation inhibitors
por: Piecyk, Karolina, et al.
Publicado: (2014) -
Hydrolytic activity of human Nudt16 enzyme on dinucleotide cap analogs and short capped oligonucleotides
por: Grzela, Renata, et al.
Publicado: (2018) -
Decapping Scavenger Enzyme Activity toward N2-Substituted
5′ End mRNA Cap Analogues
por: Pietrow, Paulina, et al.
Publicado: (2019) -
Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential
por: Strenkowska, Malwina, et al.
Publicado: (2016)